In Brief: Smoking cessation product sales
This article was originally published in The Tan Sheet
Executive Summary
Smoking cessation product sales: SmithKline Beecham's Nicorette, available since April, leads the market with sales of $135.7 mil. and an 81% market share for the period ended Sept. 8, according to Information Resources, Inc. three-outlet figures. McNeil's Nicotrol follows, generating sales of $16.6 mil. (12.3% share) since its July launch. SmithKline's Nicoderm CQ, with $8.5 mil. in sales since its August launch, holds 6.2% of the market...